CRMI: China Regenerative Medicine International Limited Partner with University of Oxford and CCB International (Holdings) Limited Establishing a Strategic Platform for Industrialisation of Biomedical Research Results
- Written by EQS Asia Business News
(EQS-News / 22/10/2015 / 21:49 UTC+8) 22 October 2015 (stock code:8158.HK) China Regenerative Medicine International Limited Partner with University of Oxford and CCB International (Holdings) LimitedEstablishing a Strategic Platform for Industrialisation of Biomedical Research Results (21 October, 2015 - the United Kingdom) China Regenerative... |

